Evidence map›Paper›PMID 20080675›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Reconstructed evolutionary adaptive paths give polymerases accepting reversible terminators for sequencing and SNP detection.

Fei Chen, Eric A Gaucher, Nicole A Leal, Daniel Hutter, Stephanie A Havemann, Sridhar Govindarajan, Eric A Ortlund, Steven A Benner

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Engineering Polymerases for New Functions.Trends in biotechnology · 2019
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Alternative Watson-Crick Synthetic Genetic Systems.Cold Spring Harbor perspectives in biology · 2016
    Review
  19. The Toolbox for Modified Aptamers.Molecular biotechnology · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Fei ChenFoundation for Applied Molecular Evolution, 720 SW 2nd Avenue, Suite 201, Gainesville, FL 32601, USA.
Eric A Gaucher
Nicole A Leal
Daniel Hutter
Stephanie A Havemann
Sridhar Govindarajan
Eric A Ortlund
Steven A Benner
Foundation for Applied Molecular Evolution · USATUM (United States) · USEmory University · USGeorgia Institute of Technology · US

Funding

Near Term Development of Reagents and Enzymes for Genome SequencingR01HG004831 · NHGRI · FOUNDATION FOR APPLIED MOLECULAR EVOLUTN · PI BENNER, STEVEN A · 2008 to 2010
$1.4M
Alkoxylamine nucleosides for sequencing by synthesisR42HG003668 · NHGRI · INTELLIGENT BIO-SYSTEMS, INC. · PI BENNER, STEVEN A · 2008 to 2009
$933k
Evolutionary Approaches for synthetic Library DesignR41GM074433 · NIGMS · DNA TWOPOINTO, INC. · PI GAUCHER, ERIC · 2006 to 2006
$121k
An Expanded Genetic Information SystemR41GM063368 · NIGMS · ERAGEN BIOSCIENCES, INC. · PI BENNER, STEVEN A · 2001 to 2001
$100k
Multipurpose reversible terminatorsR41HG004589 · NHGRI · FIREBIRD BIOMOLECULAR SCIENCES, LLC · PI HUTTER, DANIEL · 2008 to 2008
$100k
NHGRI NIH HHS 2R42HG003668-02ANHGRI NIH HHS R01 HG004831NHGRI NIH HHS R01HG004831NHGRI NIH HHS R41 HG004589NHGRI NIH HHS R41HG004589NHGRI NIH HHS R42 HG003668NIGMS NIH HHS 1R41GM074433NIGMS NIH HHS R41 GM063368NIGMS NIH HHS R41 GM074433
6 · The paper itself

Abstract

Any system, natural or human-made, is better understood if we analyze both its history and its structure. Here we combine structural analyses with a "Reconstructed Evolutionary Adaptive Path" (REAP) analysis that used the evolutionary and functional history of DNA polymerases to replace amino acids to enable polymerases to accept a new class of triphosphate substrates, those having their 3'-OH ends blocked as a 3(')-ONH(2) group (dNTP-ONH(2)). Analogous to widely used 2',3'-dideoxynucleoside triphosphates (ddNTPs), dNTP-ONH(2)s terminate primer extension. Unlike ddNTPs, however, primer extension can be resumed by cleaving an O-N bond to restore an -OH group to the 3'-end of the primer. REAP combined with crystallographic analyses identified 35 sites where replacements might improve the ability of Taq to accept dNTP-ONH(2)s. A library of 93 Taq variants, each having replacements at three or four of these sites, held eight variants having improved ability to accept dNTP-ONH(2) substrates. Two of these (A597T, L616A, F667Y, E745H, and E520G, K540I, L616A) performed notably well. The second variant incorporated both dNTP-ONH(2)sand ddNTPs faithfully and efficiently, supporting extension-cleavage-extension cycles applicable in parallel sequencing and in SNP detection through competition between reversible and irreversible terminators. Dissecting these results showed that one replacement (L616A), not previously identified, allows Taq to incorporate both reversible and irreversible terminators. Modeling showed how L616A might open space behind Phe-667, allowing it to move to accommodate the larger 3'-substituent. This work provides polymerases for DNA analyses and shows how evolutionary analyses help explore relationships between structure and function in proteins.

Indexed as

Amino Acid SubstitutionBase SequenceCatalytic DomainDNA PrimersEvolution, MolecularGenetic VariationModels, MolecularPolymorphism, Single NucleotideSequence Analysis, DNASubstrate SpecificityTaq PolymeraseDNA PrimersTaq Polymerase

Identifiers

PMID20080675
PMCPMC2804741
OpenAlexW2127960534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.